Patents by Inventor Taiji Tsukamoto

Taiji Tsukamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETECTING BLADDER CANCER CELLS, PRIMER USED IN METHOD FOR DETECTING BLADDER CANCER CELLS, AND BLADDER CANCER MARKER
    Publication number: 20150024389
    Abstract: Provided are: a method for detecting bladder cancer with high detection sensitivity, which has a high specificity for bladder cancer and is capable of detecting bladder cancer tissues with low grade of malignancy; and a bladder cancer marker. A method for detecting bladder cancer cells, which comprises detection of the amount of expressed bladder cancer marker in a subject sample collected from a subject, said bladder cancer marker being composed of one or more miRNAs selected from among miR-124, miR-9 and miR-137; a primer which is used in the method for detecting bladder cancer cells; and a bladder cancer marker.
    Type: Application
    Filed: March 14, 2012
    Publication date: January 22, 2015
    Applicant: LSIP, LLC
    Inventors: Takashi Shimizu, Hiromu Suzuki, Minoru Toyota, Taiji Tsukamoto
  • Identification marker responsive to interferon therapy for renal cell cancer
    Patent number: 7838229
    Abstract: The present invention provides an identification marker responsive to IFN therapy for renal cell cancer and a means of detecting the same. Namely, a method which comprises preparing a genomic DNA of a human gene or a complementary strand thereof from a specimen of a patient with renal cell cancer, analyzing the DNA sequence of the genomic DNA or the complementary strand thereof to determine the gene polymorphism of the human gene, and evaluating the tumor-suppression effect of IFN therapy on renal cell cancer by using the polymorphism as an indicator.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: November 23, 2010
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Toyokazu Seki, Takayuki Shiratsuchi, Osamu Ogawa, Seiji Naito, Taiji Tsukamoto, Hiroshi Toma, Yoshihiko Hirao, Susumu Kagawa, Yoshiaki Nose, Tsuyoshi Nakamura
  • Identification Marker Responsive to Interferon Therapy for Renal Cell Cancer
    Publication number: 20080199859
    Abstract: The present invention provides an identification marker responsive to IFN therapy for renal cell cancer and a means of detecting the same. Namely, a method which comprises preparing a genomic DNA of a human gene or a complementary strand thereof from a specimen of a patient with renal cell cancer, analyzing the DNA sequence of the genomic DNA or the complementary strand thereof to determine the gene polymorphism of the human gene, and evaluating the tumor-suppression effect of IFN therapy on renal cell cancer by using the polymorphism as an indicator.
    Type: Application
    Filed: October 24, 2005
    Publication date: August 21, 2008
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Toyokazu Seki, Takayuki Shiratsuchi, Osamu Ogawa, Seiji Naito, Taiji Tsukamoto, Hiroshi Toma, Yoshihiko Hirao, Susumu Kagawa, Yoshiaki Nose, Tsuyoshi Nakamura